EQ Equillium, Inc.

Nasdaq equilliumbio.com


$ 1.24 $ -0.01 (-0.8 %)    

Tuesday, 14-Oct-2025 11:32:51 EDT
QQQ $ 596.96 $ 1.74 (0.29 %)
DIA $ 460.25 $ 3.25 (0.71 %)
SPY $ 659.85 $ 2.56 (0.39 %)
TLT $ 90.53 $ -0.11 (-0.12 %)
GLD $ 380.80 $ 2.47 (0.65 %)
$ 1.28
$ 1.25
$ 1.24 x 1,200
$ 1.25 x 930
$ 1.22 - $ 1.26
$ 0.27 - $ 2.35
630,093
na
76.16M
$ 0.56
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-14-2025 06-30-2025 10-Q
2 05-14-2025 03-31-2025 10-Q
3 03-27-2025 12-31-2024 10-K
4 11-13-2024 09-30-2024 10-Q
5 08-08-2024 06-30-2024 10-Q
6 05-09-2024 03-31-2024 10-Q
7 03-25-2024 12-31-2023 10-K
8 11-08-2023 09-30-2023 10-Q
9 08-09-2023 06-30-2023 10-Q
10 05-11-2023 03-31-2023 10-Q
11 03-23-2023 12-31-2022 10-K
12 11-14-2022 09-30-2022 10-Q
13 08-15-2022 06-30-2022 10-Q
14 05-12-2022 03-31-2022 10-Q
15 03-23-2022 12-31-2021 10-K
16 11-10-2021 09-30-2021 10-Q
17 08-10-2021 06-30-2021 10-Q
18 05-13-2021 03-31-2021 10-Q
19 03-24-2021 12-31-2020 10-K
20 11-10-2020 09-30-2020 10-Q
21 08-12-2020 06-30-2020 10-Q
22 05-13-2020 03-31-2020 10-Q
23 03-26-2020 12-31-2019 10-K
24 11-12-2019 09-30-2019 10-Q
25 08-12-2019 06-30-2019 10-Q
26 05-13-2019 03-31-2019 10-Q
27 03-27-2019 12-31-2018 10-K
28 11-15-2018 09-30-2018 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 equillium-files-prospectus-for-75m-share-offering

-SEC Filing

 equillium-files-for-offering-of-up-to-5263m-shares-of-common-stock-by-selling-stockholders

-SEC Filing

 why-is-equillium-stock-soaring-monday

Equillium stock is trading higher Monday after the company announced up to $50 million in financing through a securities purcha...

 equillium-announces-strategic-expansion-to-integrate-cryptocurrency-treasury-reserve-strategy-as-part-of-its-broader-financial-and-growth-objectives

Equillium, Inc. (NASDAQ:EQ), a biotechnology innovator developing novel therapies to treat severe autoimmune and inflammatory d...

 equillium-shares-resume-trade
Equillium Shares Resume Trade
08/01/2025 19:13:24

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION